News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
India’s Piramal Healthcare Limited Denies Reports of Stake Sale to Pfizer Inc.
May 19, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- India's Piramal Healthcare Ltd on Wednesday denied media reports the founders were selling a stake in the drug maker, pushing its shares down more than 8 percent.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Asia
Pfizer
MORE ON THIS TOPIC
Collaboration
Lilly Bulks Up Inflammatory Pipeline With $1.2B Ventyx Buy, InduPro Cancer Pact
January 8, 2026
·
2 min read
·
Tristan Manalac
Layoffs
Biopharmas Axed 47% More Employees Year Over Year
January 8, 2026
·
5 min read
·
Angela Gabriel
Cancer
Pfizer Searches for Novel Tumor-Selective Antigens With $865M+ Cartography Pact
January 7, 2026
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Amgen Makes up to $840M Cancer Play With Dark Blue Takeover
January 7, 2026
·
1 min read
·
Tristan Manalac
